Association for Research in Vision and Ophthalmology

Association for Research in Vision and Ophthalmology

Issue: June 25, 2017
May 14, 2017
1 min watch
Save

VIDEO: Sirolimus reduces vitreous haze in patients with posterior uveitis

Issue: June 25, 2017
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BALTIMORE – Phase 3 studies of intravitreal sirolimus demonstrated reduced vitreous haze in patients with noninfectious posterior uveitis, Peter K. Kaiser, MD, reported at the Association for Research in Vision and Ophthalmology meeting here. The drug is under FDA review.